Oxford BioDynamics Plc
Oxford BioDynamics Plc (OBD.L) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Oxford BioDynamics Plc (OBD.L), featuring income statements, balance sheets, and cash flow data.
Oxford BioDynamics Plc (OBD.L) Income Statement & Financial Overview
Analyze Oxford BioDynamics Plc’s OBD.L earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $309000.00 | $327000.00 | $290000.00 | $220000.00 |
| Cost of Revenue | $3.63M | $4.20M | $3.91M | $3.43M |
| Gross Profit | -$3.32M | -$3.87M | -$3.62M | -$3.21M |
| Gross Profit Ratio | -$10.73 | -$11.83 | -$12.48 | -$14.58 |
| R&D Expenses | $484000.00 | $325000.00 | $474000.00 | $284000.00 |
| SG&A Expenses | $2.28M | $2.20M | $1.94M | $1.47M |
| Operating Expenses | $2.76M | $2.52M | $2.42M | $1.75M |
| Total Costs & Expenses | -$6.39M | $6.72M | $6.33M | $5.18M |
| Interest Income | $79000.00 | $33000.00 | $48000.00 | $55000.00 |
| Interest Expense | $406000.00 | $117000.00 | $123000.00 | $90000.00 |
| Depreciation & Amortization | $740000.00 | $728000.00 | $747000.00 | $610000.00 |
| EBITDA | -$5.93M | -$4.03M | -$5.29M | -$4.35M |
| EBITDA Ratio | -$19.21 | -$12.32 | -$18.24 | -$19.76 |
| Operating Income | -$6.08M | -$6.39M | -$6.04M | -$4.96M |
| Operating Income Ratio | -$19.67 | -$19.56 | -$20.82 | -$22.54 |
| Other Income/Expenses (Net) | -$1.002M | $1.52M | -$622000.00 | $206000.00 |
| Income Before Tax | -$7.08M | -$4.88M | -$6.66M | -$4.75M |
| Income Before Tax Ratio | -$22.92 | -$14.91 | -$22.96 | -$21.60 |
| Income Tax Expense | -$239000.00 | -$150000.00 | -$276000.00 | -$309000.00 |
| Net Income | -$6.84M | -$4.72M | -$6.38M | -$4.44M |
| Net Income Ratio | -$22.14 | -$14.45 | -$22.01 | -$20.20 |
| EPS | -$0.02 | -$0.02 | -$0.04 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.04 | -$0.03 |
| Weighted Avg Shares Outstanding | $311.86M | $202.30M | $153.94M | $139.10M |
| Weighted Avg Shares Outstanding (Diluted) | $311.86M | $202.30M | $153.94M | $139.10M |
Over the last four quarters, Oxford BioDynamics Plc's revenue moved from $220000.00 in Q2 2023 to $309000.00 in Q4 2024. Operating income in Q4 2024 was -$6.08M, with a strong operating margin of -1967%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Oxford BioDynamics Plc remained robust at -$5.93M, reflecting operational efficiency. Net income dropped to -$6.84M, with an EPS of -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan